Here are four observations:
1. OsteoSelect PLUS is a next-generation DBM putty and is comprised of OsteoSelect Putty with demineralized cortical chips.
2. Xtant Medical is prepared to launch OsteoSelect PLUS to customers in the fourth quarter of 2015.
3. This is the first 510(k) approval for Bacterin since becoming a subsidiary of Xtant Medical.
4. Xtant Medical develops and markets regenerative medicine products and medical devices for a number of markets, including orthopedics and neurology.
More articles on devices:
ulrich medical to expand North American corporate division: 4 notes
Exactech shares drop 0.66% — 5 notes
Global neurosurgical products market to reach $7.7B by 2022 & 5 other key trends
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
